Guillermo Ramirez v. E.I. Dupont De Nemours & Company, a Foreign Corporation , 454 F. App'x 760 ( 2011 )


Menu:
  •                                                        [DO NOT PUBLISH]
    IN THE UNITED STATES COURT OF APPEALS
    FOR THE ELEVENTH CIRCUIT
    FILED
    ________________________        U.S. COURT OF APPEALS
    ELEVENTH CIRCUIT
    DECEMBER 13, 2011
    No. 11-10035
    JOHN LEY
    Non-Argument Calendar
    CLERK
    ________________________
    D. C. Docket No. 8:09-cv-00321-VMC-TBM
    GUILLERMO RAMIREZ,
    Plaintiff-Appellant,
    versus
    E.I. DUPONT DE NEMOURS & COMPANY,
    a foreign corporation,
    Defendant-Appellee.
    ________________________
    Appeal from the United States District Court
    for the Middle District of Florida
    ________________________
    (December 13, 2011)
    Before DUBINA, Chief Judge, HULL and BLACK, Circuit Judges.
    PER CURIAM:
    This is an appeal from a district court’s judgment entered on a jury verdict
    in a product liability case. The plaintiff-appellant, Guillermo Ramirez
    (“Ramirez”), alleged in his complaint that he used E.I. du Pont de Nemours &
    Company’s (“Du Pont”) product Benlate in conjunction with his farming
    operations. Ramirez asserted that Benlate is a defective product because it
    contains a known carcinogen: Atrazine. Ramirez filed his complaint alleging strict
    liability and negligence. He also contended that the use of Benlate caused him to
    contract cancer.
    The case was tried to a jury and the jury, on special interrogatories, returned
    a verdict favorable to Du Pont. Specifically, although the jury found that Benlate
    was a defective product, it did not find that the Benlate was the cause of Ramirez’s
    cancer. The district court, after denying Ramirez’s Rule 50(b) Federal Rule of
    Civil Procedure motion for judgment as a matter of law and new trial on damages,
    or in the alternative, Rule 50(b) and Rule 59(a) motion for new trial, entered a
    judgment on the jury’s verdict. Ramirez then perfected this appeal.
    This court reviews a district court’s determination of a motion for judgment
    as a matter of law or new trial de novo. Ross v. Rhodes Furniture, Inc., 
    146 F.3d 1286
    , 1289 (11th Cir. 1998); Quick v. Peoples Bank, 
    993 F.2d 793
    , 797 (11th Cir.
    2
    1993). We review a district court’s Daubert1 rulings under an abuse of discretion
    standard. McClain v Metabolife International, Inc., 
    401 F.3d 1233
    , 1238 (11th
    Cir. 2005).
    After reviewing the record and reading the parties’ briefs, we see no reason
    to disturb the jury’s verdict and the final judgment entered for Du Pont. First,
    Ramirez argues that the verdict in the case was inconsistent because it determined
    that Du Pont’s product, Benlate, was defective, but that such product was not the
    cause of Ramirez’s injuries. We agree with the district court that Ramirez’s
    argument lacks merit because defect and causation are separate elements of the
    causes of action at issue, and it was proper for the jury to evaluate them separately.
    Accordingly, we agree with the district court that the verdict was not inconsistent.
    We also agree with the district court that the jury’s verdict was not contrary
    to the overwhelming weight of the evidence in the case. The record supports that
    the jury was presented with numerous plausible reasons for determining that
    Benlate did not cause Ramirez’s cancer. For example, the jury heard that when
    Ramirez sprayed his crops, he rode inside an enclosed tractor cab, wore protective
    clothing, including goggles, a mask, a jumpsuit, gloves and boots, and had
    minimal exposure to the chemicals. Additionally, the jury was presented with
    1
    Daubert v. Merrell Dow Pharmaceuticals, Inc., 
    509 U.S. 579
    , 
    113 S. Ct. 2786
     (1993).
    3
    evidence demonstrating that Ramirez had a history of diabetes, obesity, high
    cholesterol, high blood pressure and a family history of cancer. Moreover, the
    jury heard that Ramirez had a history of smoking cigarettes. Finally, the jury
    heard expert testimony tending to show that the Benlate in question did not
    contain contaminates at a level high enough to cause Ramirez’s injuries.
    The law is clear in this circuit that a district court should only grant a
    judgment as a matter of law or new trial when the verdict is against the clear
    weight of the evidence or will result in a miscarriage of justice. See Lipphardt v.
    Durango Steakhouse of Brandon, Inc., 
    267 F.3d 1183
    , 1186 (11th Cir. 2001);
    Hewitt v. B.F. Goodrich Co., 
    732 F.2d 1554
    , 1556 (11th Cir. 1984). We agree
    with the district court’s finding that Ramirez failed to satisfy his high burden for
    obtaining a new trial or a judgment as a matter of law on the basis of the weight of
    the evidence.
    Finally, Ramirez attacks Du Pont’s expert, Dr. Cohen by contending that the
    testimony of Dr. Cohen should have been stricken. We disagree. Dr. Cohen is
    one of the world’s leading experts in cancer and chemical causation and he
    considered the type of scientific and factual information that experts in his field
    would reasonably rely upon. The opinions he offered at trial were not speculative,
    and he did not make improper assumptions. Accordingly, we see no abuse of
    4
    discretion in the district court’s permitting Dr. Cohen to testify as an expert
    witness and in refusing to strike Dr. Cohen’s opinions.
    For the foregoing reasons, we affirm the district court’s judgment entered on
    the jury’s verdict.
    AFFIRMED.
    5